Solorank.ai
Login

Cached score snapshot

US.HUM · Humana

110分制 53/110；5D動能v2 8/50；排序分 61/160

Back to ranking Open volume snapshot
Ranking score 61/160
Main score 53/110
5D momentum v2 8/50
Rank #293
Setup grade F 25.6

Score breakdown

避免

Elevated twelvedata

Score and price trend

F 25.6 Elevated risk

Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.

Move the mouse over the chart lines to inspect readings.

0 40 80 110 Score 04-21 07-22 08-04 08-17 08-27 $191.52$337.65$483.78 Price Projection date
Historical projection
Model Median P25/P75 歷史相似情境上漲比例 Down5 Actual / compare
Rolling DOE best · score 2.897 · anchors 120 +0.51% -1.49% / +3.36% 56.2% 3.2% Actual +4.62% · vs median +4.11% · inside 25-75 band
30D observation +8.21% +0.45% / +14.88% 76.8% 12.4% Actual outcome pending · 1 / 30 bars observed
Historical projection 10D n=160 +1.12% -0.99% / +3.54% 62.5% 1.9% Actual outcome pending · 1 / 10 bars observed

歷史情境統計基於已存檔相似 setup；圖中投影中位線為統計中位數的線性插值展示，並非價格路徑預測或買賣建議。

2026-04-21 → 2026-08-27 · 351 archived points · 2 Improving turn signal · 9 Deteriorating signal

Summary

score_with_momentum_v2 = main score + 5D momentum v2

Ranking score 61
Display grade 避免
Model version cursor_18_27_news_v2_160
Main score 53/110 (避免)
5D momentum v2 8/50 (弱)
Score with momentum v2 61/160 (低排序)
Risk level Elevated

Audit trace

Full calculation detail

Calculation detail · 8 sections

Market inputs

Bar count 60
ma20 386.8525
ma50 344.7634
close 386.48
prevClose 407.78
avgVolume20 1547816
volumeRatio 1.45
changePercent -5.22

Metrics snapshot

close 386.48
volume 2237817
changePercent -5.22

110-point main rating

基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10

Main score 53/110
Main rating 避免
5D momentum v2 8/50
Score with momentum v2 61/160
Formula score_with_momentum_v2 = main_score + momentum_5d_v2_score

基本面 — 2.8/5 · 較差
Dimension score 2.8/5
Dimension grade 較差

Sub-items

pbPoints 0.4
pePoints 0.2
epsPoints 0
roePoints 0
debtPoints 0.5
marginPoints 0
turnoverUsdM 864.8715
volumePoints 0.5
revenuePoints 0.4
dividendPoints 0.3
marketCapPoints 0.5

資金流 — 11.6/20 · 較差
Dimension score 11.6/20
Dimension grade 較差

Sub-items

cmfPoints 0.8
mfiPoints 2.4
obvPoints 2.4
vwapPoints 4

institutional

score 2

details

source optional-neutral

warning

code INSTITUTIONAL_DATA_OPTIONAL
symbol US.HUM
message Institutional ownership is unavailable; neutral 2/4 money-flow treatment used.
optional true
holderCount n/a
holderPoints 2
top10ShareRatio n/a
concentrationPenalty 0
institutionPoints 2

市場環境 — 10/15 · 一般
Dimension score 10/15
Dimension grade 一般

Sub-items

vix

score 2.4

details

source twelvedata+fred
vixClose 15.67

trend

score 2.4

details

qqq

ma20 719.7045
ma50 718.7308
name QQQ
close 705.94
points 0.4

spy

ma20 744.9045
ma50 743.99
name SPY
close 750.72
points 2
source twelvedata+fred
atrPct 4.1492
atrPoints 2
cciPoints 3.2
vixPoints 2.4
marketTrendPoints 2.4

催化劑 — 2/20 · 較差
Dimension score 2/20
Dimension grade 較差

Sub-items

catalyst

score 2

details

source finnhub_news_keyword_model
articleCount 8
catalystCount 0
catalystPoints 2

風險管理 — 5.9/10 · 較差
Dimension score 5.9/10
Dimension grade 較差

Sub-items

position

score 1.3

details

atrPct 4.1492
turnoverUsdM 864.8715
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.HUM
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 354.4084

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 8.3
take_profit_price 419.487
target_multiplier 1.9
technical_strength 1.63
take_profit_percent 8.5
positionPoints 1.3
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 8.2984
diversificationPoints 2

技術信號 — 16.7/30 · 較差
Dimension score 16.7/30
Dimension grade 較差

Sub-items

bbPoints 2.4
adxPoints 3
sarPoints 1.2
vcpPoints 1.6
macdPoints 2.4

vcpPayload

vcp_pass false
vcp_score 1.6
vcp_reason 波幅收縮(25.1%→7%)；站上MA50；Ready=N；Confirm=N

vcp_metrics

up_days 6
vol_ref 1448960
down_days 3
vcp_ready false
above_ma50 true
avg_vol_10 1315420
avg_vol_20 1520780
avg_vol_30 1448960
range_pct_10 0.0696
range_pct_20 0.1603
range_pct_30 0.2506
up_expand_ok false
lookback_used 59
near_20d_high true
contraction_ok true
down_shrink_ok false
up_expand_days 1
breakout_20d_ok false
vol_ratio_10_30 0.9078
dist_to_20d_high 0.0687
down_shrink_days 2
breakout_level_20d 415
vcp_breakout_confirm false
contraction_ratio_10_30 0.2777
vcp_name_en Volatility Contraction Pattern
vcp_name_zh 波動收縮形態
vol_contraction true
kdjAdxPoints 0.5
rsiKdjPoints 2.4
volumeWeight 2
maCrossPoints 1.6
shortRsiPoints 0
shortMacdPoints 0.4
volConfirmPoints 0
volumePointsTechnical 1.2

情緒分析 — 4/10 · 較差
Dimension score 4/10
Dimension grade 較差

Sub-items

sentiment

score 4

details

source finnhub_news_keyword_model
articleCount 8
negativeHits 0
positiveHits 3
sentimentScoreRaw 0.9

sentimentData

raw {"id":140922832,"url":"https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.","category":"company","datetime":1784218802,"headline":"Can Humana (HUM) Run Higher on Rising Earnings Estimates?"}, {"id":140906296,"url":"https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...","category":"company","datetime":1784095786,"headline":"Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"}, {"id":140893488,"url":"https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499","image":"","source":"Fintel","related":"HUM","summary":"","category":"company","datetime":1783995721,"headline":"Wells Fargo Upgrades Humana (HUM)"}, {"id":140844596,"url":"https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...","category":"company","datetime":1783538028,"headline":"Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"}, {"id":140727523,"url":"https://finnhub.io/api/news?id=bee44d6e5e80ea447ad95d16b14bdf466a6dd9bf5bb059b006cf14e4dd1bc5f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:HUM) and its peers.","category":"company","datetime":1782406670,"headline":"Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)"}, {"id":140722892,"url":"https://finnhub.io/api/news?id=12b0414fd5accf3aa8ddbb092a2cc160affcb446696073985e2d3470b52b978e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"In June 2026, the Illinois Department of Healthcare and Family Services selected Humana Inc. to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program covering 102 counties, with Humana’s HealthChoice plan expected to begin operations in January 2027. At the same time, investors are weighing this new Medicaid opportunity against concerns raised by a preliminary 2027 Medicare Advantage rate update and Humana’s own ambitious membership growth expectations...","category":"company","datetime":1782367644,"headline":"Illinois HealthChoice Medicaid Win Could Be A Game Changer For Humana’s (HUM) Margin Story"}, {"id":140721384,"url":"https://finnhub.io/api/news?id=509ea44470fd9b220f5ef5120f56ce309109d173a5fb9026a6098288f98cda4d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana has been selected to join Illinois' statewide Medicaid managed care program, HealthChoice Illinois. Following this selection, the company plans to launch its HealthChoice Illinois offering in January 2027, expanding its Medicaid presence in the state. Humana (NYSE:HUM) is adding a new chapter to its government program footprint with its entry into HealthChoice Illinois, a statewide Medicaid managed care program. The stock recently closed at $361.64, with returns of 17.4% over the...","category":"company","datetime":1782353311,"headline":"Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027"}, {"id":140701640,"url":"https://finnhub.io/api/news?id=e87ec26e7443e12896d45adaa9be25cb0124f100504a4bce324831904b20c779","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Pzena Investment Management recently released its first-quarter 2026 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The equity market faced challenges in the first quarter due to the Iran conflict and the related energy price hike, compounded by continued AI-related uncertainty. Despite this volatility, energy stocks led the […]","category":"company","datetime":1782220201,"headline":"Here’s What Hit Humana (HUM) in Q1"}
raw_source {"id":140926098,"url":"https://finnhub.io/api/news?id=a3ed218800a97680c73e07aa6bb488836ce3c983719dca490e71b4cd424977f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.","category":"company","datetime":1784233476,"headline":"UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates"}, {"id":140924354,"url":"https://finnhub.io/api/news?id=6beff7ff98afeafc7e69e28d5375177dc8b70c8486507b5409de1426713e60de","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs, sending the Dow Jones stock surging past a buy point on Thursday morning. Rival managed-care providers including Humana, Centene and Elevance Health got a sizable lift from the initial warm reception for UnitedHealth's earnings report. Results: UnitedHealth posted Q2 earnings per share of $6.38, up 56% from a weak year-earlier result and 30% ahead of $4.91 forecasts.","category":"company","datetime":1784230057,"headline":"Why UNH Stock Breakout Faltered After Massive Earnings Beat"}, {"id":140922832,"url":"https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.","category":"company","datetime":1784218802,"headline":"Can Humana (HUM) Run Higher on Rising Earnings Estimates?"}, {"id":140921098,"url":"https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.","category":"company","datetime":1784213644,"headline":"UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"}, {"id":140920951,"url":"https://finnhub.io/api/news?id=4edc50fb0c0b3163368a3ac06c10ca151d88a91c32421f42358d93e3f325254f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.","category":"company","datetime":1784211300,"headline":"Sandisk, Micron, TSMC, UnitedHealth, and More Stocks That Explain Today’s Market"}, {"id":140923118,"url":"https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103","image":"https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.","category":"company","datetime":1784208257,"headline":"UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"}, {"id":140919761,"url":"https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.","category":"company","datetime":1784207995,"headline":"The Medicaid Problem That Swallowed an Earnings Beat"}, {"id":140919767,"url":"https://finnhub.io/api/news?id=5bce92d51784c68c7f17ff30ac90cfadc42527df5e6f98bcf7d33ff3a800eb62","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.","category":"company","datetime":1784205720,"headline":"Inside the UnitedHealth Earnings Beat That Lifted Healthcare Stocks"}, {"id":140919291,"url":"https://finnhub.io/api/news?id=195f8e2045a457bd41c82088ca85aafdc16620b26b540f6e0008b4d2a9b08064","image":"https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp","source":"ChartMill","related":"HUM","summary":"The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.","category":"company","datetime":1784205300,"headline":"What's going on in today's pre-market session: S&P500 movers"}, {"id":140919768,"url":"https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.","category":"company","datetime":1784205032,"headline":"The Medicaid Problem Weighing On Elevance Health Stock"}, {"id":140919728,"url":"https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.","category":"company","datetime":1784205031,"headline":"The Real Price of Admission for CVS Health Stock"}, {"id":140919679,"url":"https://finnhub.io/api/news?id=54e2d3441d9dc3c895613df0f8f0e6192543381b162933236b00e7b8c37b72f6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.","category":"company","datetime":1784204340,"headline":"Sandisk, UnitedHealth, J.B. Hunt, TSMC, and More Stocks That Explain Today’s Market"}, {"id":140920007,"url":"https://finnhub.io/api/news?id=b05572daf0c4b7738b01cacb08bf0110183587e578a16a35f389f0c74c58a89a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth (UNH) delivered earnings and revenue surprises of +29.15% and +1.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?","category":"company","datetime":1784199902,"headline":"UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates"}, {"id":140918841,"url":"https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook. Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.","category":"company","datetime":1784199650,"headline":"UNH Stock Flashes Buy Signal On Massive Earnings Beat"}, {"id":140918843,"url":"https://finnhub.io/api/news?id=cf5cb36802c45abb2a183490e32f65c7eec1280c026b62d4e243a0196161334b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.","category":"company","datetime":1784198280,"headline":"UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost"}, {"id":140923188,"url":"https://finnhub.io/api/news?id=d85d188ac31f0be7b67de702da053ebe6f33ee097b1395995d39e56ab6610ae9","image":"https://cdn.benzinga.com/files/images/story/2026/07/16/GLP-1.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you","category":"company","datetime":1784193389,"headline":"Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027"}, {"id":140914116,"url":"https://finnhub.io/api/news?id=e9db35be5692d32311636bfb2d472068853dd38721681a09228157e8ca04b9d7","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1163752700/image_1163752700.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"Humana stock surged 106% on Medicare Advantage optimism, but margins and earnings lag and valuation looks stretched. Click for more on HUM stock.","category":"company","datetime":1784137230,"headline":"Humana: Q2 Earnings Must Catch Up With The Stock"}, {"id":140907461,"url":"https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.","category":"company","datetime":1784114481,"headline":"Insurance stocks fall after Elevance Health results show margin pressure"}, {"id":140906296,"url":"https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...","category":"company","datetime":1784095786,"headline":"Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"}, {"id":140901947,"url":"https://finnhub.io/api/news?id=5f3fef99ff0df0cac06252e71b332ffd16257eb940089d3f03c9ff846d60da6c","image":"","source":"Benzinga","related":"HUM","summary":"TD Cowen analyst Ryan Langston maintains Humana (NYSE:HUM) with a Hold and raises the price target from $211 to $350.","category":"company","datetime":1784028528,"headline":"TD Cowen Maintains Hold on Humana, Raises Price Target to $350"}, {"id":140901948,"url":"https://finnhub.io/api/news?id=3c52092a2a30d09e2f4291941a91a1161fec0a8e29e89d8fa52bd0d1ff2215ef","image":"","source":"Benzinga","related":"HUM","summary":"Truist Securities analyst David Macdonald maintains Humana (NYSE:HUM) with a Hold and raises the price target from $320 to $415.","category":"company","datetime":1784021510,"headline":"Truist Securities Maintains Hold on Humana, Raises Price Target to $415"}, {"id":140893488,"url":"https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499","image":"","source":"Fintel","related":"HUM","summary":"","category":"company","datetime":1783995721,"headline":"Wells Fargo Upgrades Humana (HUM)"}, {"id":140890161,"url":"https://finnhub.io/api/news?id=e25110c78ca2177615e41497f4272b141937d60a5e1b269003abf9d7270f7d7c","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and","category":"company","datetime":1783971281,"headline":"Sector Update: Healthcare Stocks Advance Late Afternoon"}, {"id":140890023,"url":"https://finnhub.io/api/news?id=495aea92af0bbd7e19a383216dfbd22c522dee63025845643456bbfaa14d3c16","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.","category":"company","datetime":1783965840,"headline":"Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch"}, {"id":140890002,"url":"https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.","category":"company","datetime":1783965262,"headline":"The Premium On CVS Stock Vs What Its Peers Deliver"}, {"id":140888416,"url":"https://finnhub.io/api/news?id=fd4d4d323ca3fedefea2cc6d440ffd8cf63824e0800c451fe6d924a57bcada11","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.","category":"company","datetime":1783960620,"headline":"Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?"}, {"id":140885931,"url":"https://finnhub.io/api/news?id=d9bd3e5a447e59b21f811bc30301952ad049da7bb5153d18da437fe995ccd6e2","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"American Express, Biogen upgraded: Wall Street's top analyst calls","category":"company","datetime":1783950101,"headline":"American Express, Biogen upgraded: Wall Street's top analyst calls"}, {"id":140888858,"url":"https://finnhub.io/api/news?id=2ee353ba4819573ae59d8207240fe4802587c3ae7f9647c9333653e00912cd13","image":"","source":"Benzinga","related":"HUM","summary":"Wells Fargo analyst Stephen Baxter upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $227 to $502.","category":"company","datetime":1783929218,"headline":"Wells Fargo Upgrades Humana to Overweight, Raises Price Target to $502"}, {"id":140865405,"url":"https://finnhub.io/api/news?id=43b032537d5346775647011af917abc702bf8a42f9ad7ce1513fce3cdf3d5099","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.","category":"company","datetime":1783707000,"headline":"Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?"}, {"id":140864271,"url":"https://finnhub.io/api/news?id=2e1f4d2e2bd8a771190b14a8e47325fa8f08b3d3b73ff3f485a97a763923bec7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.","category":"company","datetime":1783700700,"headline":"Is ELV's Capital Allocation Strategy Creating Long-Term Value?"}, {"id":140864272,"url":"https://finnhub.io/api/news?id=8cb9ceee7f486eaba0b4c7d9e75a7a6713c50af11938b8057df4ec2e73f044c6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.","category":"company","datetime":1783700580,"headline":"Can UNH's Lifestyle Spending Account Redefine Employee Benefits?"}, {"id":140861604,"url":"https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.","category":"company","datetime":1783684540,"headline":"UNH Showered Owners With Cash. The Stock Did Not Cooperate"}, {"id":140860584,"url":"https://finnhub.io/api/news?id=b0b89f578c00f4ef5ee36881a23109c43fd7c57d2231e57e1adfbc28747b77a6","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16","category":"company","datetime":1783683039,"headline":"The Main Reason Behind Buying UnitedHealth Before July 16"}, {"id":140860865,"url":"https://finnhub.io/api/news?id=3534cd0756dbc13bd4612d305a212cd65ae36ef9141d04b1b4365039c50b020f","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1278842473/image_1278842473.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"The S&P 500 declined 0.95% as market leadership rotated away from mega-cap tech. Read more here.","category":"company","datetime":1783671000,"headline":"Broadening Market Lifts Moat Stocks In June"}, {"id":140854725,"url":"https://finnhub.io/api/news?id=4d4ba33028b72345771b2d6177ef4a48ef6331e93a1f3ef095b421cf04b71092","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”","category":"company","datetime":1783622061,"headline":"Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”"}, {"id":140851085,"url":"https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.","category":"company","datetime":1783604827,"headline":"The Real Price of UnitedHealth Stock Isn't on Today's Label"}, {"id":140865176,"url":"https://finnhub.io/api/news?id=b5b0d6d80e9f8fc9b7209c25c2b2b814f79658f1aba834769155c9e2eafae44d","image":"","source":"Benzinga","related":"HUM","summary":"RBC Capital analyst Ben Hendrix maintains Humana (NYSE:HUM) with a Sector Perform and raises the price target from $246 to $415.","category":"company","datetime":1783603928,"headline":"RBC Capital Maintains Sector Perform on Humana, Raises Price Target to $415"}, {"id":140844596,"url":"https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...","category":"company","datetime":1783538028,"headline":"Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"}, {"id":140843416,"url":"https://finnhub.io/api/news?id=5dd1d143f06f4fa4eb3d3a97880fa22ffc1c5de99e6a64d0a7dcb18a4055d14a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.","category":"company","datetime":1783524300,"headline":"UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?"}, {"id":140834545,"url":"https://finnhub.io/api/news?id=2b9ad6b049d73243c2c7d8cc8764c34538c16d53083e94ef5b89809c55698234","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.","category":"company","datetime":1783430767,"headline":"Humana Earnings Preview: What to Expect"}, {"id":140830888,"url":"https://finnhub.io/api/news?id=7e0083af50961ff361349709b6916fd6b5d1b8e4b89f6a2ba577c788e6b954a8","image":"","source":"Benzinga","related":"HUM","summary":"Cantor Fitzgerald analyst Sarah James maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $264 to $300.","category":"company","datetime":1783410797,"headline":"Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300"}, {"id":140822476,"url":"https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.","category":"company","datetime":1783354301,"headline":"What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"}, {"id":140819581,"url":"https://finnhub.io/api/news?id=ede26e95f8cd574ded4ee784a40075275bfa1057664adeed1fd210da7b21e2f2","image":"https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208348437/image_2208348437.jpg?io=getty-c-w1536","source":"SeekingAlpha","related":"HUM","summary":"CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.","category":"company","datetime":1783327970,"headline":"CVS Health: The Surprising Healthcare Outlier"}, {"id":140807752,"url":"https://finnhub.io/api/news?id=db7dccf806f73313f5852acc19a832bddeba826f9f5173bb131d4479cbbcd12e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]","category":"company","datetime":1783174832,"headline":"Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”"}, {"id":140799596,"url":"https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.","category":"company","datetime":1783081253,"headline":"The Unpopular Move That Telegraphed the Elevance Health Stock Surge"}, {"id":140791579,"url":"https://finnhub.io/api/news?id=8dc403fbee8db8aad1d942b0a90f0ef7b4aed8b012426ecb0dbfe2b55e9d2556","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.","category":"company","datetime":1782999120,"headline":"PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare"}, {"id":140792257,"url":"https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2","image":"https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080","source":"CNBC","related":"HUM","summary":"CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.","category":"company","datetime":1782933515,"headline":"Meta's new cloud business will be instantly profitable, says Jim Cramer"}, {"id":140772839,"url":"https://finnhub.io/api/news?id=6a277ca3b6991ab8e80b88b14bee749319d8ff8f2a6c7597e280f0b5c316b8da","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UnitedHealth Group (UNH) is likely to report second-quarter earnings above Wall Street's consensus,","category":"company","datetime":1782828758,"headline":"UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says"}, {"id":140772135,"url":"https://finnhub.io/api/news?id=7c0b16820ebd282600b26a580e95b5d32062b8fb552556b1e38962e35c874e2a","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., June 30, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.","category":"company","datetime":1782820800,"headline":"The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants"}, {"id":140771643,"url":"https://finnhub.io/api/news?id=933974103b907b1d72be4a7f5132c37cde71a5380376053b69d31f5124d9c4b7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"DarioHealth Corp. (NASDAQ: DRIO) (the \"Company\", \"DarioHealth\" or \"Dario\"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.","category":"company","datetime":1782819000,"headline":"Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships"}, {"id":140774740,"url":"https://finnhub.io/api/news?id=bac1556681a38492c41d8ad99cae5880494ce345262ebc615ded85f7f7858fe6","image":"https://cdn.benzinga.com/files/images/story/2026/06/30/Two-Injectors-Dosing-Pens-For-Subcutaneo.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility and access.","category":"company","datetime":1782808093,"headline":"Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday"}, {"id":140781618,"url":"https://finnhub.io/api/news?id=c2b9cf7db5e8e7b511f80cba972d4339f22d420c6b2bd7054751c0b254645eec","image":"https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080","source":"CNBC","related":"HUM","summary":"The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.","category":"company","datetime":1782795601,"headline":"Medicare will start covering obesity drugs for the first time. Here's what patients should know"}, {"id":140781757,"url":"https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e","image":"https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080","source":"CNBC","related":"HUM","summary":"The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.","category":"company","datetime":1782760725,"headline":"Tuesday's big stock stories: What’s likely to move the market in the next trading session"}, {"id":140762586,"url":"https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.","category":"company","datetime":1782744240,"headline":"How CenterWell Is Driving Humana's Growth Beyond Insurance"}, {"id":140761652,"url":"https://finnhub.io/api/news?id=ec9490d78d2bbdede75602bb26eb289d1c5b1536c79f6283f5756d1080b4670b","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.","category":"company","datetime":1782737415,"headline":"2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges"}, {"id":140738020,"url":"https://finnhub.io/api/news?id=21eee8397f16e7d74095ad3cf7e8fc458841490e5fdbb2389cbf7c1ad40e1088","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.","category":"company","datetime":1782488700,"headline":"Can Carelon Drive Elevance Health's Future Earnings Growth?"}, {"id":140739246,"url":"https://finnhub.io/api/news?id=47ec2a2209086a44ad157e6195ed8a0ffc0e3023569ffaf896991b26b1a9e44d","image":"https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536","source":"Benzinga","related":"HUM","summary":"This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often","category":"company","datetime":1782480916,"headline":"4 Health Care Stocks With Whale Alerts In Today’s Session"}, {"id":140727523,"url":"https://finnhub.io/api/news?id=bee44d6e5e80ea447ad95d16b14bdf466a6dd9bf5bb059b006cf14e4dd1bc5f7","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:HUM) and its peers.","category":"company","datetime":1782406670,"headline":"Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)"}, {"id":140722892,"url":"https://finnhub.io/api/news?id=12b0414fd5accf3aa8ddbb092a2cc160affcb446696073985e2d3470b52b978e","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"In June 2026, the Illinois Department of Healthcare and Family Services selected Humana Inc. to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program covering 102 counties, with Humana’s HealthChoice plan expected to begin operations in January 2027. At the same time, investors are weighing this new Medicaid opportunity against concerns raised by a preliminary 2027 Medicare Advantage rate update and Humana’s own ambitious membership growth expectations...","category":"company","datetime":1782367644,"headline":"Illinois HealthChoice Medicaid Win Could Be A Game Changer For Humana’s (HUM) Margin Story"}, {"id":140721384,"url":"https://finnhub.io/api/news?id=509ea44470fd9b220f5ef5120f56ce309109d173a5fb9026a6098288f98cda4d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Humana has been selected to join Illinois' statewide Medicaid managed care program, HealthChoice Illinois. Following this selection, the company plans to launch its HealthChoice Illinois offering in January 2027, expanding its Medicaid presence in the state. Humana (NYSE:HUM) is adding a new chapter to its government program footprint with its entry into HealthChoice Illinois, a statewide Medicaid managed care program. The stock recently closed at $361.64, with returns of 17.4% over the...","category":"company","datetime":1782353311,"headline":"Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027"}, {"id":140715750,"url":"https://finnhub.io/api/news?id=392deaad22fa5d18fbbb3de9a0bc3c25155defe608767ed47db42f65e079bfee","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.","category":"company","datetime":1782314700,"headline":"Can Humana's Margin Recovery Drive Long-Term Earnings Growth?"}, {"id":140717417,"url":"https://finnhub.io/api/news?id=f93a7b0ca1dfb02867de7f467ea74e8f67e8135f808359459d41c664d4a49722","image":"","source":"Benzinga","related":"HUM","summary":"B of A Securities analyst Kevin Fischbeck maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $340 to $380.","category":"company","datetime":1782306501,"headline":"B of A Securities Maintains Neutral on Humana, Raises Price Target to $380"}, {"id":140701640,"url":"https://finnhub.io/api/news?id=e87ec26e7443e12896d45adaa9be25cb0124f100504a4bce324831904b20c779","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Pzena Investment Management recently released its first-quarter 2026 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The equity market faced challenges in the first quarter due to the Iran conflict and the related energy price hike, compounded by continued AI-related uncertainty. Despite this volatility, energy stocks led the […]","category":"company","datetime":1782220201,"headline":"Here’s What Hit Humana (HUM) in Q1"}, {"id":140700233,"url":"https://finnhub.io/api/news?id=c38b12817fb689102db462d2ccc0c2143ee8414e2dbef5846012f7b7e08a8efc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]","category":"company","datetime":1782203748,"headline":"CVS Health (CVS) Under the Microscope After Recent Healthcare Report"}, {"id":140696392,"url":"https://finnhub.io/api/news?id=89966c567aa0ab9e59469cab4e15beaf49cb48582424b9116a541e6eceb483af","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., June 22, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.","category":"company","datetime":1782160200,"headline":"Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026"}, {"id":140695049,"url":"https://finnhub.io/api/news?id=2e2c3f7497742be1643d4d2e86e0e0da6e322ecfb2e9f5e7b47237a31fca7eea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.","category":"company","datetime":1782147060,"headline":"UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?"}, {"id":140670778,"url":"https://finnhub.io/api/news?id=bd1ba6eea0be8b23e57da68e8f92f21d120cf2fa9b34ed6a99ffd07d72b5c036","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.","category":"company","datetime":1781882218,"headline":"1 S&P 500 Stock on Our Buy List and 2 We Ignore"}, {"id":140670004,"url":"https://finnhub.io/api/news?id=33a5887422971ea693f377a69701553c8ff339624ea7d20c1726ffa301283a0d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Former CEOs of Humana and CVS Health have been appointed as advisors to Optura, an AI focused healthcare startup. UnitedHealth Group (NYSE:UNH) is participating on the advisory side, aligning with efforts to measure and optimize return on AI investment in healthcare. The collaboration brings together major US health insurers and service providers around a shared AI platform approach. For UnitedHealth Group, a large diversified health insurer and services company, this move puts more focus...","category":"company","datetime":1781871116,"headline":"UnitedHealth (UNH) Joins Optura As Former Humana And CVS Chiefs Sign On"}, {"id":140663313,"url":"https://finnhub.io/api/news?id=dfefa937c73e1028e63f187f3dc3fd241e34d9a0f4ea7c8917b5c00c2affc29f","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.","category":"company","datetime":1781798248,"headline":"2 High-Flying Stocks to Target This Week and 1 Facing Challenges"}, {"id":140669985,"url":"https://finnhub.io/api/news?id=3befb971a581643ef5598128a12003139593bfcadd0c717c21c370431db4c2ea","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.","category":"company","datetime":1781789400,"headline":"3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound"}, {"id":140662486,"url":"https://finnhub.io/api/news?id=e95c2dd2427c646b59ca687256cb6365d1581d8409a47d6c6504ec991f1c20cc","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Optura, the enterprise healthcare platform that delivers ROAI™ (Return on AI Investment), today announced that Bruce Broussard, former President and CEO of Humana, and Karen Lynch, former President and CEO of CVS Health, have joined the company as strategic advisors, alongside a broader group of advisors from Humana, Optum, UnitedHealth Group, Horizon Blue Cross Blue Shield, BlueCross BlueShield of Tennessee, and Boston Consulting Group.","category":"company","datetime":1781787600,"headline":"Bruce Broussard and Karen Lynch Lead a Group of Healthcare and Music Industry Luminaries Joining Optura as Strategic Advisors"}, {"id":140652753,"url":"https://finnhub.io/api/news?id=f816292c4cc1a836354f9db6258b904847bb65dcad6c9dd3e2a121251f9b0be8","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., June 17, 2026--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State","category":"company","datetime":1781697600,"headline":"Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State"}, {"id":140645758,"url":"https://finnhub.io/api/news?id=920d7e0373fa1f369733ebdb85721d3ee12e827e4bb631d1c07561d28b3c699d","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.","category":"company","datetime":1781624687,"headline":"Why Did UnitedHealth Stock Choose Pain Over Growth?"}, {"id":140644635,"url":"https://finnhub.io/api/news?id=a0cb1ba10580396788827af3aae39c4050267d5c2d9d9d8e7b5e974e1ea28020","image":"https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png","source":"Yahoo","related":"HUM","summary":"LOUISVILLE, Ky., June 16, 2026--Humana, CenterWell and National Hispanic Medical Association announce 2026 Resident Physician Scholarship Program recipients.","category":"company","datetime":1781607600,"headline":"Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients"}
data_source finnhub_news_keyword_model
article_count 8
negative_hits 0
positive_hits 3
recomputed_at_score true
sentiment_score_raw 0.9
source_article_count 74
discarded_article_count 66
sentimentPoints 4

Dimension contribution

Dimension Raw Max Norm % Contrib
基本面 2.8 5/110 56% 2.8
資金流 11.6 20/110 58% 11.6
市場環境 10 15/110 66.67% 10
催化劑 2 20/110 10% 2
風險管理 5.9 10/110 59% 5.9
技術信號 16.7 30/110 55.67% 16.7
情緒分析 4 10/110 40% 4

5D momentum v2 breakdown

Cursor_18.25 5D momentum v2 0-50

5D momentum v2 8/50
ret_5d -0.0284
max_score 50
max_total 50
raw_total 8
vcp_bonus 0
vol_ratio 1.4715
ret_points 0
vol_points 4
range_ratio 3.3051
volat_points 4
day_range_pct 0.113
model_version cursor_18_27_news_v2_160
available_bars 30
breakout_points 0
partial_history false
pullback_points 0
breakout_vol_bonus 0
first_breakout_20d false
return_window_days 5
first_breakout_bonus 0
breakout_quality_points 0

Risk management

level Elevated
reason risk management score >= 5/10

position

score 1.3

details

atrPct 4.1492
turnoverUsdM 864.8715
liquidityPoints 0.6
volatilityPoints 0.7
rrPoints 1.4

stopLevels

symbol US.HUM
rr_range 1:1.0-1:2.5
risk_profile 中等
stop_loss_price 354.4084

strength_details

ma_score 1.5
atr_score 1
rsi_score 2
macd_score 1.5
volume_score 2
market_adjustment 1
risk_reward_ratio 1
stop_loss_percent 8.3
take_profit_price 419.487
target_multiplier 1.9
technical_strength 1.63
take_profit_percent 8.5
positionPoints 1.3
stopLossPoints 1.2

diversification

score 2

details

method sector concentration proxy; no portfolio holdings used
sector Health Care
concentratedSectorPenalty 0
riskRewardRatio 1.2
stopLossPercent 8.2984
diversificationPoints 2

Calculation audit log

基本面分析總分: 2.8/5分
資金流分析總分: 11.6/20分
市場環境分析總分: 10/15分
催化劑分析: 2/20分
風險管理總分: 5.9/10分
技術信號分析總分: 16.7/30分
情緒分析: 4/10分
共振率(僅顯示不加分): 0%

Technical indicators

adx
value 92.86
atr
atr 16.0358
rule ATR / current price; lower volatility scores higher
score 4
atr_pct 4.15
cci
rule Cursor_18.24 CCI bands
level 適中偏強
score 8
value 57.98
cmf
rule Cursor_18.24 CMF bands
level 派發
score 2
value -0.0826
kdj
d 58.91
j 19.32
k 45.71
rule Cursor_18.24 K/D cross
score 0
signal 死叉
mfi
rule Cursor_18.24 MFI bands
level 平衡
score 6
value 51.69
obv
rule Cursor_18.24 recent_slope vs previous_slope
score 6
trend 有流入
value 34036383
recentSlope 155278.3
previousSlope 415530
rsi
value 55.39
sar
rule Cursor_18.24 Parabolic SAR
score 4
trend 下降
value 415
position SAR喺價上
distancePct 7.38
previousTrend 上升
ma50
value 344.7634
macd
macd 16.206
trend 中性偏多
signal 19.0198
histogram -2.8138
vwap
rule Cursor_18.24 VWAP 20D consecutive close
score 10
value 384.8844
position 連續5日>VWAP
consecutiveAbove 41
volume
rule Cursor_18.24 volume ratio
level 有量
ratio 1.45
score 6
avgVolume 1547816
currentVolume 2237817
derived
ma20 386.8525
ma50 344.7634
prevClose 407.78
avgVolume10 1370272
avgVolume20 1547816
changePercent -5.22
avgVolumeForScore 1547816
ma_cross
ma20 386.8525
ma50 344.7634
rule Cursor_18.24 MA20/MA50 cross
cross 多頭
score 4
prevMa20 386.003
prevMa50 341.793
spreadPct 12.21
isVolumeBreakout true
bollinger
lower 352.8766
upper 420.8284
position 中間
rsi_short
value 38.82
macd_short
macd 0
trend 中性
signal 0
histogram 0
volume_ratio
ratio 1.45

Raw calculation JSON

 
{
  "risk": {
    "level": "Elevated",
    "reason": "risk management score >= 5/10",
    "position": {
      "score": 1.3,
      "details": {
        "atrPct": 4.149192606365332,
        "turnoverUsdM": 864.87153653817,
        "liquidityPoints": 0.6,
        "volatilityPoints": 0.7
      }
    },
    "rrPoints": 1.4,
    "stopLevels": {
      "symbol": "US.HUM",
      "rr_range": "1:1.0-1:2.5",
      "risk_profile": "中等",
      "stop_loss_price": 354.4084,
      "strength_details": {
        "ma_score": 1.5,
        "atr_score": 1,
        "rsi_score": 2,
        "macd_score": 1.5,
        "volume_score": 2
      },
      "market_adjustment": 1,
      "risk_reward_ratio": 1,
      "stop_loss_percent": 8.3,
      "take_profit_price": 419.487,
      "target_multiplier": 1.9,
      "technical_strength": 1.63,
      "take_profit_percent": 8.5
    },
    "positionPoints": 1.3,
    "stopLossPoints": 1.2,
    "diversification": {
      "score": 2,
      "details": {
        "method": "sector concentration proxy; no portfolio holdings used",
        "sector": "Health Care",
        "concentratedSectorPenalty": 0
      }
    },
    "riskRewardRatio": 1.2,
    "stopLossPercent": 8.298385212730665,
    "diversificationPoints": 2
  },
  "total": {
    "max": 160,
    "result": 61,
    "formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
    "baseScore": 53,
    "modelVersion": "cursor_18_27_news_v2_160",
    "momentum5dScore": 8
  },
  "market": {
    "ma20": 386.8525,
    "ma50": 344.7634,
    "close": 386.48,
    "prevClose": 407.78,
    "avgVolume20": 1547816,
    "volumeRatio": 1.45,
    "changePercent": -5.22
  },
  "sources": {
    "catalyst": "finnhub_news_keyword_model",
    "sentiment": "finnhub_news_keyword_model",
    "fundamentals": "fmp_stable",
    "institutional": null,
    "marketContext": "twelvedata+fred"
  },
  "barCount": 60,
  "momentum": {
    "max": 50,
    "result": 8,
    "details": {
      "ret_5d": -0.02835880861929796,
      "max_score": 50,
      "max_total": 50,
      "raw_total": 8,
      "vcp_bonus": 0,
      "vol_ratio": 1.4714929181078131,
      "ret_points": 0,
      "vol_points": 4,
      "range_ratio": 3.3050545890559344,
      "volat_points": 4,
      "day_range_pct": 0.11297300991065475,
      "model_version": "cursor_18_27_news_v2_160",
      "available_bars": 30,
      "breakout_points": 0,
      "partial_history": false,
      "pullback_points": 0,
      "breakout_vol_bonus": 0,
      "first_breakout_20d": false,
      "return_window_days": 5,
      "first_breakout_bonus": 0,
      "breakout_quality_points": 0
    },
    "formula": "Cursor_18.25 5D momentum v2 0-50",
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "scoreMax": 110,
  "composite": {
    "max": 160,
    "result": 61,
    "formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
    "weights": [
      {
        "raw": 2.8,
        "label": "基本面",
        "weight": "5/110",
        "normalized": 56,
        "contribution": 2.8
      },
      {
        "raw": 11.6,
        "label": "資金流",
        "weight": "20/110",
        "normalized": 58,
        "contribution": 11.6
      },
      {
        "raw": 10,
        "label": "市場環境",
        "weight": "15/110",
        "normalized": 66.67,
        "contribution": 10
      },
      {
        "raw": 2,
        "label": "催化劑",
        "weight": "20/110",
        "normalized": 10,
        "contribution": 2
      },
      {
        "raw": 5.9,
        "label": "風險管理",
        "weight": "10/110",
        "normalized": 59,
        "contribution": 5.9
      },
      {
        "raw": 16.7,
        "label": "技術信號",
        "weight": "30/110",
        "normalized": 55.67,
        "contribution": 16.7
      },
      {
        "raw": 4,
        "label": "情緒分析",
        "weight": "10/110",
        "normalized": 40,
        "contribution": 4
      }
    ],
    "modelVersion": "cursor_18_27_news_v2_160"
  },
  "momentumMax": 50,
  "scoreStatus": "checked",
  "standard110": {
    "rating": "避免",
    "result": 53,
    "details": [
      "基本面分析總分: 2.8/5分",
      "資金流分析總分: 11.6/20分",
      "市場環境分析總分: 10/15分",
      "催化劑分析: 2/20分",
      "風險管理總分: 5.9/10分",
      "技術信號分析總分: 16.7/30分",
      "情緒分析: 4/10分",
      "共振率(僅顯示不加分): 0%"
    ],
    "formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
    "dimensionScores": {
      "催化劑": 2,
      "基本面": 2.8,
      "資金流": 11.6,
      "市場環境": 10,
      "情緒分析": 4,
      "技術信號": 16.7,
      "風險管理": 5.9
    },
    "dimensionDetails": {
      "催化劑": {
        "max": 20,
        "grade": "較差",
        "items": {
          "catalyst": {
            "score": 2,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "catalystCount": 0
            }
          },
          "catalystPoints": 2
        }
      },
      "基本面": {
        "max": 5,
        "grade": "較差",
        "items": {
          "pbPoints": 0.4,
          "pePoints": 0.2,
          "epsPoints": 0,
          "roePoints": 0,
          "debtPoints": 0.5,
          "marginPoints": 0,
          "turnoverUsdM": 864.87153653817,
          "volumePoints": 0.5,
          "revenuePoints": 0.4,
          "dividendPoints": 0.3,
          "marketCapPoints": 0.5
        },
        "source": "fmp_stable"
      },
      "資金流": {
        "max": 20,
        "grade": "較差",
        "items": {
          "cmfPoints": 0.8,
          "mfiPoints": 2.4,
          "obvPoints": 2.4,
          "vwapPoints": 4,
          "institutional": {
            "score": 2,
            "details": {
              "source": "optional-neutral",
              "warning": {
                "code": "INSTITUTIONAL_DATA_OPTIONAL",
                "symbol": "US.HUM",
                "message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
              },
              "optional": true,
              "holderCount": null,
              "holderPoints": 2,
              "top10ShareRatio": null,
              "concentrationPenalty": 0
            }
          },
          "institutionPoints": 2
        }
      },
      "市場環境": {
        "max": 15,
        "grade": "一般",
        "items": {
          "vix": {
            "score": 2.4,
            "details": {
              "source": "twelvedata+fred",
              "vixClose": 15.67
            }
          },
          "trend": {
            "score": 2.4,
            "details": {
              "qqq": {
                "ma20": 719.70450385,
                "ma50": 718.7308020400001,
                "name": "QQQ",
                "close": 705.94,
                "points": 0.4
              },
              "spy": {
                "ma20": 744.9045070000001,
                "ma50": 743.9900025,
                "name": "SPY",
                "close": 750.71997,
                "points": 2
              },
              "source": "twelvedata+fred"
            }
          },
          "atrPct": 4.149192606365332,
          "atrPoints": 2,
          "cciPoints": 3.2,
          "vixPoints": 2.4,
          "marketTrendPoints": 2.4
        }
      },
      "情緒分析": {
        "max": 10,
        "grade": "較差",
        "items": {
          "sentiment": {
            "score": 4,
            "details": {
              "source": "finnhub_news_keyword_model",
              "articleCount": 8,
              "negativeHits": 0,
              "positiveHits": 3,
              "sentimentScoreRaw": 0.9
            }
          },
          "sentimentData": {
            "raw": [
              {
                "id": 140922832,
                "url": "https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",
                "category": "company",
                "datetime": 1784218802,
                "headline": "Can Humana (HUM) Run Higher on Rising Earnings Estimates?"
              },
              {
                "id": 140906296,
                "url": "https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...",
                "category": "company",
                "datetime": 1784095786,
                "headline": "Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"
              },
              {
                "id": 140893488,
                "url": "https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1783995721,
                "headline": "Wells Fargo Upgrades Humana (HUM)"
              },
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              },
              {
                "id": 140727523,
                "url": "https://finnhub.io/api/news?id=bee44d6e5e80ea447ad95d16b14bdf466a6dd9bf5bb059b006cf14e4dd1bc5f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:HUM) and its peers.",
                "category": "company",
                "datetime": 1782406670,
                "headline": "Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)"
              },
              {
                "id": 140722892,
                "url": "https://finnhub.io/api/news?id=12b0414fd5accf3aa8ddbb092a2cc160affcb446696073985e2d3470b52b978e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In June 2026, the Illinois Department of Healthcare and Family Services selected Humana Inc. to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program covering 102 counties, with Humana’s HealthChoice plan expected to begin operations in January 2027. At the same time, investors are weighing this new Medicaid opportunity against concerns raised by a preliminary 2027 Medicare Advantage rate update and Humana’s own ambitious membership growth expectations...",
                "category": "company",
                "datetime": 1782367644,
                "headline": "Illinois HealthChoice Medicaid Win Could Be A Game Changer For Humana’s (HUM) Margin Story"
              },
              {
                "id": 140721384,
                "url": "https://finnhub.io/api/news?id=509ea44470fd9b220f5ef5120f56ce309109d173a5fb9026a6098288f98cda4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has been selected to join Illinois' statewide Medicaid managed care program, HealthChoice Illinois. Following this selection, the company plans to launch its HealthChoice Illinois offering in January 2027, expanding its Medicaid presence in the state. Humana (NYSE:HUM) is adding a new chapter to its government program footprint with its entry into HealthChoice Illinois, a statewide Medicaid managed care program. The stock recently closed at $361.64, with returns of 17.4% over the...",
                "category": "company",
                "datetime": 1782353311,
                "headline": "Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027"
              },
              {
                "id": 140701640,
                "url": "https://finnhub.io/api/news?id=e87ec26e7443e12896d45adaa9be25cb0124f100504a4bce324831904b20c779",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pzena Investment Management recently released its first-quarter 2026 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The equity market faced challenges in the first quarter due to the Iran conflict and the related energy price hike, compounded by continued AI-related uncertainty. Despite this volatility, energy stocks led the […]",
                "category": "company",
                "datetime": 1782220201,
                "headline": "Here’s What Hit Humana (HUM) in Q1"
              }
            ],
            "raw_source": [
              {
                "id": 140926098,
                "url": "https://finnhub.io/api/news?id=a3ed218800a97680c73e07aa6bb488836ce3c983719dca490e71b4cd424977f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Stronger medical costs and better-than-expected quarterly profit lifted guidance and boosted confidence in the earnings recovery.",
                "category": "company",
                "datetime": 1784233476,
                "headline": "UnitedHealth Jumps 10.3% After Raising 2026 EPS Outlook Above Estimates"
              },
              {
                "id": 140924354,
                "url": "https://finnhub.io/api/news?id=6beff7ff98afeafc7e69e28d5375177dc8b70c8486507b5409de1426713e60de",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs, sending the Dow Jones stock surging past a buy point on Thursday morning.  Rival managed-care providers including Humana, Centene and Elevance Health got a sizable lift from the initial warm reception for UnitedHealth's earnings report.  Results: UnitedHealth posted Q2 earnings per share of $6.38, up 56% from a weak year-earlier result and 30% ahead of $4.91 forecasts.",
                "category": "company",
                "datetime": 1784230057,
                "headline": "Why UNH Stock Breakout Faltered After Massive Earnings Beat"
              },
              {
                "id": 140922832,
                "url": "https://finnhub.io/api/news?id=e159efa51fcde7c20305a1b028edd02584d44509cfc7889cd3f3c3d3360cc646",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.",
                "category": "company",
                "datetime": 1784218802,
                "headline": "Can Humana (HUM) Run Higher on Rising Earnings Estimates?"
              },
              {
                "id": 140921098,
                "url": "https://finnhub.io/api/news?id=3ee3e86383b3ce5a581b714972278ee2441b8d4bec1066462ce8d89a05a83334",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Insurance giant UnitedHealth Group (UNH) is out with its second quarter earnings on Thursday, raising its full-year outlook alongside its reported $112 billion in quarterly revenue. The stock has jumped in Thursday trading. Mizuho Americas healthcare equity strategist Jared Holz takes a closer look at the insurer's stock performance and the role Medicare Advantage had in its figures.",
                "category": "company",
                "datetime": 1784213644,
                "headline": "UnitedHealth stock jumps on Q2 earnings, raises full-year outlook"
              },
              {
                "id": 140920951,
                "url": "https://finnhub.io/api/news?id=4edc50fb0c0b3163368a3ac06c10ca151d88a91c32421f42358d93e3f325254f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.",
                "category": "company",
                "datetime": 1784211300,
                "headline": "Sandisk, Micron, TSMC, UnitedHealth, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140923118,
                "url": "https://finnhub.io/api/news?id=849660181dbdce21c5283300d80d1ffbd4882504fe8ef32a9722935ced89a103",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/Konskie--Poland---September-07--2025-Uni.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "UnitedHealth's (UNH) strong earnings and raised outlook lifted healthcare ETFs despite a sharp decline in Medicare Advantage membership.",
                "category": "company",
                "datetime": 1784208257,
                "headline": "UnitedHealth Rally Sparks Bullish Case for Healthcare ETFs Despite Medicare Advantage Losses"
              },
              {
                "id": 140919761,
                "url": "https://finnhub.io/api/news?id=9e2d7a9c3858d95b05e36040d4d9fa67670edc9e6fdf517dd74ddb28b77b88f9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health raised its profit forecast and the stock promptly fell. Here’s the one number that explains why investors headed for the exits.",
                "category": "company",
                "datetime": 1784207995,
                "headline": "The Medicaid Problem That Swallowed an Earnings Beat"
              },
              {
                "id": 140919767,
                "url": "https://finnhub.io/api/news?id=5bce92d51784c68c7f17ff30ac90cfadc42527df5e6f98bcf7d33ff3a800eb62",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.",
                "category": "company",
                "datetime": 1784205720,
                "headline": "Inside the UnitedHealth Earnings Beat That Lifted Healthcare Stocks"
              },
              {
                "id": 140919291,
                "url": "https://finnhub.io/api/news?id=195f8e2045a457bd41c82088ca85aafdc16620b26b540f6e0008b4d2a9b08064",
                "image": "https://www.chartmill.com/images/uploads/CM_Premarket_Movers_Small_free_90289f6b81.webp",
                "source": "ChartMill",
                "related": "HUM",
                "summary": "The US market is yet to commence its session on Thursday, but let's get a preview of the pre-market session and explore the top S&P500 gainers and losers driving the early market movements.",
                "category": "company",
                "datetime": 1784205300,
                "headline": "What's going on in today's pre-market session: S&P500 movers"
              },
              {
                "id": 140919768,
                "url": "https://finnhub.io/api/news?id=f42558d6ad029166956228b7d675af30dc5b6485d970b7e2c2615347057d3dd9",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock is priced for strength, but a deep and persistent drag from one of its largest divisions could challenge the optimistic narrative.",
                "category": "company",
                "datetime": 1784205032,
                "headline": "The Medicaid Problem Weighing On Elevance Health Stock"
              },
              {
                "id": 140919728,
                "url": "https://finnhub.io/api/news?id=ea562688189364310e928b87698b0b1ae06ad5b160972c5e0599966669084dc2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.",
                "category": "company",
                "datetime": 1784205031,
                "headline": "The Real Price of Admission for CVS Health Stock"
              },
              {
                "id": 140919679,
                "url": "https://finnhub.io/api/news?id=54e2d3441d9dc3c895613df0f8f0e6192543381b162933236b00e7b8c37b72f6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "AMD, Dell, Intel, and Micron shares fall as Wall Street questions how long the AI spending boom can last.",
                "category": "company",
                "datetime": 1784204340,
                "headline": "Sandisk, UnitedHealth, J.B. Hunt, TSMC, and More Stocks That Explain Today’s Market"
              },
              {
                "id": 140920007,
                "url": "https://finnhub.io/api/news?id=b05572daf0c4b7738b01cacb08bf0110183587e578a16a35f389f0c74c58a89a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth (UNH) delivered earnings and revenue surprises of +29.15% and +1.74%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?",
                "category": "company",
                "datetime": 1784199902,
                "headline": "UnitedHealth Group (UNH) Q2 Earnings and Revenues Surpass Estimates"
              },
              {
                "id": 140918841,
                "url": "https://finnhub.io/api/news?id=7fc32469cbc32693e09225dbb6db0e9326b415c41557fdcf85b7c7c9d24b74f5",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group crushed Q2 earnings forecasts amid lower-than-expected benefit costs and gave a big boost to its full-year outlook.  Humana, Centene and CVS Health all got a sizable lift from the warm reception for UnitedHealth's earnings report.",
                "category": "company",
                "datetime": 1784199650,
                "headline": "UNH Stock Flashes Buy Signal On Massive Earnings Beat"
              },
              {
                "id": 140918843,
                "url": "https://finnhub.io/api/news?id=cf5cb36802c45abb2a183490e32f65c7eec1280c026b62d4e243a0196161334b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant posts better-than-expected second-quarter earnings and hikes its full-year guidance.",
                "category": "company",
                "datetime": 1784198280,
                "headline": "UnitedHealth Earnings Crush Estimates and Give These Stocks a Boost"
              },
              {
                "id": 140923188,
                "url": "https://finnhub.io/api/news?id=d85d188ac31f0be7b67de702da053ebe6f33ee097b1395995d39e56ab6610ae9",
                "image": "https://cdn.benzinga.com/files/images/story/2026/07/16/GLP-1.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "A weight-loss prescription that runs $149 to $449 a month at the pharmacy counter now costs some Medicare enrollees $50. Across a year, that is the difference between roughly $600 and more than $4,000, and whether you",
                "category": "company",
                "datetime": 1784193389,
                "headline": "Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027"
              },
              {
                "id": 140914116,
                "url": "https://finnhub.io/api/news?id=e9db35be5692d32311636bfb2d472068853dd38721681a09228157e8ca04b9d7",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1163752700/image_1163752700.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "Humana stock surged 106% on Medicare Advantage optimism, but margins and earnings lag and valuation looks stretched. Click for more on HUM stock.",
                "category": "company",
                "datetime": 1784137230,
                "headline": "Humana: Q2 Earnings Must Catch Up With The Stock"
              },
              {
                "id": 140907461,
                "url": "https://finnhub.io/api/news?id=d9e07d894e9e87b569ae71b67f25b242f8405d36966fddfe8c414ae2975ec6b2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Investing.com -- Elevance Health’s Health Benefits operating profit collapsed in the second quarter of 2026, igniting a broad premarket selloff across the managed-care sector even as the insurer’s headline earnings handily beat estimates and full-year guidance was lifted.",
                "category": "company",
                "datetime": 1784114481,
                "headline": "Insurance stocks fall after Elevance Health results show margin pressure"
              },
              {
                "id": 140906296,
                "url": "https://finnhub.io/api/news?id=aefc94a8790a12b4b318ed41cc626501ef5d050689c4d921a17296962e36b41a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana stock at a glance Humana (HUM) has drawn investor attention after a strong past year, with the stock up 86% on a total return basis and a share price that last closed at US$406.77. That move sits alongside a reported value score of 3 and an indicated intrinsic discount of 61%. This raises questions about how the market currently weighs Humana’s insurance and CenterWell operations. See our latest analysis for Humana. The recent 7.3% 30 day share price return and 105.1% 90 day share...",
                "category": "company",
                "datetime": 1784095786,
                "headline": "Humana (HUM) Rallies On Conflicting Valuation Views, Is It Fully Priced?"
              },
              {
                "id": 140901947,
                "url": "https://finnhub.io/api/news?id=5f3fef99ff0df0cac06252e71b332ffd16257eb940089d3f03c9ff846d60da6c",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "TD Cowen  analyst Ryan Langston   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $211 to $350.",
                "category": "company",
                "datetime": 1784028528,
                "headline": "TD Cowen Maintains Hold on Humana, Raises Price Target to $350"
              },
              {
                "id": 140901948,
                "url": "https://finnhub.io/api/news?id=3c52092a2a30d09e2f4291941a91a1161fec0a8e29e89d8fa52bd0d1ff2215ef",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Truist Securities  analyst David Macdonald   maintains Humana (NYSE:HUM) with a Hold and raises the price target from $320 to $415.",
                "category": "company",
                "datetime": 1784021510,
                "headline": "Truist Securities Maintains Hold on Humana, Raises Price Target to $415"
              },
              {
                "id": 140893488,
                "url": "https://finnhub.io/api/news?id=75f7e0e7e91cf4b0c0f9a04de4611f827f908faaf9ab8d6bbdd2937b198a8499",
                "image": "",
                "source": "Fintel",
                "related": "HUM",
                "summary": "",
                "category": "company",
                "datetime": 1783995721,
                "headline": "Wells Fargo Upgrades Humana (HUM)"
              },
              {
                "id": 140890161,
                "url": "https://finnhub.io/api/news?id=e25110c78ca2177615e41497f4272b141937d60a5e1b269003abf9d7270f7d7c",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Healthcare stocks were higher late Monday afternoon, with the NYSE Healthcare Index rising 0.2% and",
                "category": "company",
                "datetime": 1783971281,
                "headline": "Sector Update: Healthcare Stocks Advance Late Afternoon"
              },
              {
                "id": 140890023,
                "url": "https://finnhub.io/api/news?id=495aea92af0bbd7e19a383216dfbd22c522dee63025845643456bbfaa14d3c16",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth faces Q2 pressure from membership declines, but medical cost management and long-term growth initiatives keep investors focused on July 16 results.",
                "category": "company",
                "datetime": 1783965840,
                "headline": "Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch"
              },
              {
                "id": 140890002,
                "url": "https://finnhub.io/api/news?id=d8c2e200c9611f9b0e535a383ec14dcf3c85fa8c298a7875df83cf79809fe853",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant commands a premium price over its rivals, but its core numbers tell a different story. Is the market seeing a future that isn't in the results yet.",
                "category": "company",
                "datetime": 1783965262,
                "headline": "The Premium On CVS Stock Vs What Its Peers Deliver"
              },
              {
                "id": 140888416,
                "url": "https://finnhub.io/api/news?id=fd4d4d323ca3fedefea2cc6d440ffd8cf63824e0800c451fe6d924a57bcada11",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.",
                "category": "company",
                "datetime": 1783960620,
                "headline": "Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?"
              },
              {
                "id": 140885931,
                "url": "https://finnhub.io/api/news?id=d9bd3e5a447e59b21f811bc30301952ad049da7bb5153d18da437fe995ccd6e2",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "American Express, Biogen upgraded: Wall Street's top analyst calls",
                "category": "company",
                "datetime": 1783950101,
                "headline": "American Express, Biogen upgraded: Wall Street's top analyst calls"
              },
              {
                "id": 140888858,
                "url": "https://finnhub.io/api/news?id=2ee353ba4819573ae59d8207240fe4802587c3ae7f9647c9333653e00912cd13",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Wells Fargo  analyst Stephen Baxter   upgrades Humana (NYSE:HUM) from Equal-Weight to Overweight and raises the price target from $227 to $502.",
                "category": "company",
                "datetime": 1783929218,
                "headline": "Wells Fargo Upgrades Humana to Overweight, Raises Price Target to $502"
              },
              {
                "id": 140865405,
                "url": "https://finnhub.io/api/news?id=43b032537d5346775647011af917abc702bf8a42f9ad7ce1513fce3cdf3d5099",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Centene secures a four-year Illinois Medicaid contract renewal, preserving a key membership base and reinforcing long-term revenue stability.",
                "category": "company",
                "datetime": 1783707000,
                "headline": "Centene's Illinois Medicaid Renewal: A Win for Long-Term Growth?"
              },
              {
                "id": 140864271,
                "url": "https://finnhub.io/api/news?id=2e1f4d2e2bd8a771190b14a8e47325fa8f08b3d3b73ff3f485a97a763923bec7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Elevance Health's disciplined capital allocation, strong cash generation and continued investments in Carelon and AI support long-term growth while rewarding shareholders.",
                "category": "company",
                "datetime": 1783700700,
                "headline": "Is ELV's Capital Allocation Strategy Creating Long-Term Value?"
              },
              {
                "id": 140864272,
                "url": "https://finnhub.io/api/news?id=8cb9ceee7f486eaba0b4c7d9e75a7a6713c50af11938b8057df4ec2e73f044c6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth launches a Lifestyle Spending Account through UHC Store, expanding flexible wellness benefits and simplifying employer administration with digital integration.",
                "category": "company",
                "datetime": 1783700580,
                "headline": "Can UNH's Lifestyle Spending Account Redefine Employee Benefits?"
              },
              {
                "id": 140861604,
                "url": "https://finnhub.io/api/news?id=61a62b28568787b7d6c7c35482b3faf80155aede3728d9b5b2daab140f8f391b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The health care giant sent a torrent of cash to its owners, but the stock itself told a very different story about the last five years.",
                "category": "company",
                "datetime": 1783684540,
                "headline": "UNH Showered Owners With Cash. The Stock Did Not Cooperate"
              },
              {
                "id": 140860584,
                "url": "https://finnhub.io/api/news?id=b0b89f578c00f4ef5ee36881a23109c43fd7c57d2231e57e1adfbc28747b77a6",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (NYSE:UNH) carries the highest conviction among managed care names heading into the company’s July 16 earnings report, and the setup is doing the talking. Shares of UNH last traded around $430.72 on July 9, sitting on a more than 28% year-to-date gain and a more than 42% one-year return. The repricing thesis showed ... The Main Reason Behind Buying UnitedHealth Before July 16",
                "category": "company",
                "datetime": 1783683039,
                "headline": "The Main Reason Behind Buying UnitedHealth Before July 16"
              },
              {
                "id": 140860865,
                "url": "https://finnhub.io/api/news?id=3534cd0756dbc13bd4612d305a212cd65ae36ef9141d04b1b4365039c50b020f",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1278842473/image_1278842473.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "The S&P 500 declined 0.95% as market leadership rotated away from mega-cap tech. Read more here.",
                "category": "company",
                "datetime": 1783671000,
                "headline": "Broadening Market Lifts Moat Stocks In June"
              },
              {
                "id": 140854725,
                "url": "https://finnhub.io/api/news?id=4d4ba33028b72345771b2d6177ef4a48ef6331e93a1f3ef095b421cf04b71092",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Jim Cramer used his July 9, 2026 CNBC Stop Trading segment to plant a flag on managed care, framing CVS Health (NYSE:CVS) as the consolidation winner in a sector where insurers are finally getting paid for the risks they underwrite. RBC raised its price target on CVS Health, and Cramer connected that call to a ... Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”",
                "category": "company",
                "datetime": 1783622061,
                "headline": "Jim Cramer: “The Real Bull Market” Is Happening in Health Insurance. CVS Is One of the Biggest Winners as Walgreens “Basically Disappears”"
              },
              {
                "id": 140851085,
                "url": "https://finnhub.io/api/news?id=8adf9b348f35c0c0a3be660407ce5ea98e1ef6c1e2ba39157ca6bd62925c0963",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The healthcare giant looks expensive at a glance, but a patient investor is effectively buying its future earnings at a significant discount.",
                "category": "company",
                "datetime": 1783604827,
                "headline": "The Real Price of UnitedHealth Stock Isn't on Today's Label"
              },
              {
                "id": 140865176,
                "url": "https://finnhub.io/api/news?id=b5b0d6d80e9f8fc9b7209c25c2b2b814f79658f1aba834769155c9e2eafae44d",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "RBC Capital  analyst Ben Hendrix   maintains Humana (NYSE:HUM) with a Sector Perform and raises the price target from $246 to $415.",
                "category": "company",
                "datetime": 1783603928,
                "headline": "RBC Capital Maintains Sector Perform on Humana, Raises Price Target to $415"
              },
              {
                "id": 140844596,
                "url": "https://finnhub.io/api/news?id=184fcc7df54ac266e6192da5a291cdbf7d895213101ad3a3b90eeb7d6591fa09",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana’s share price has surged over the last year, yet its valuation checks paint a more balanced picture, suggesting the stock no longer looks obviously cheap or clearly expensive at current levels. Humana is up 68.6% over the past year, which puts extra focus on whether today’s price still leaves much room for error. The expansion of Humana’s Medicaid presence through the upcoming Illinois HealthChoice program can support longer term earnings potential, while investor attention on future...",
                "category": "company",
                "datetime": 1783538028,
                "headline": "Humana (HUM) Stock Stays Near Fair Value As Earnings And Growth Pull Apart"
              },
              {
                "id": 140843416,
                "url": "https://finnhub.io/api/news?id=5dd1d143f06f4fa4eb3d3a97880fa22ffc1c5de99e6a64d0a7dcb18a4055d14a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth plans to invest nearly $1.5B in AI for 2026, expanding automation, digital tools and software platforms to drive growth beyond traditional cost savings.",
                "category": "company",
                "datetime": 1783524300,
                "headline": "UNH's $1.5B AI Push: Can It Deliver More Than Cost Savings?"
              },
              {
                "id": 140834545,
                "url": "https://finnhub.io/api/news?id=2b9ad6b049d73243c2c7d8cc8764c34538c16d53083e94ef5b89809c55698234",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.",
                "category": "company",
                "datetime": 1783430767,
                "headline": "Humana Earnings Preview: What to Expect"
              },
              {
                "id": 140830888,
                "url": "https://finnhub.io/api/news?id=7e0083af50961ff361349709b6916fd6b5d1b8e4b89f6a2ba577c788e6b954a8",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Cantor Fitzgerald  analyst Sarah James   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $264 to $300.",
                "category": "company",
                "datetime": 1783410797,
                "headline": "Cantor Fitzgerald Maintains Neutral on Humana, Raises Price Target to $300"
              },
              {
                "id": 140822476,
                "url": "https://finnhub.io/api/news?id=b2e1e49bb197b35eec46ff2d4eabbd1813696e1a0e58ef55d262ac5fd33d825b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Before the stock surged, management laid out a turnaround plan for its Aetna unit that was so explicit, they practically put a price tag on it.",
                "category": "company",
                "datetime": 1783354301,
                "headline": "What CVS Health Stock Was Telling You About Its Three-Dollar Earnings Prize"
              },
              {
                "id": 140819581,
                "url": "https://finnhub.io/api/news?id=ede26e95f8cd574ded4ee784a40075275bfa1057664adeed1fd210da7b21e2f2",
                "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2208348437/image_2208348437.jpg?io=getty-c-w1536",
                "source": "SeekingAlpha",
                "related": "HUM",
                "summary": "CVS Health delivered a Q1 beat-and-raise, expects margin expansion in 2026, and projects low double-digit investor returns. Read more on CVS stock here.",
                "category": "company",
                "datetime": 1783327970,
                "headline": "CVS Health: The Surprising Healthcare Outlier"
              },
              {
                "id": 140807752,
                "url": "https://finnhub.io/api/news?id=db7dccf806f73313f5852acc19a832bddeba826f9f5173bb131d4479cbbcd12e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health Corporation (NYSE:CVS) was among the stocks Jim Cramer commented on as he advised investors on how to take advantage of Wednesday’s market rotation. Cramer showed a positive sentiment toward the stock, as he said: How about these outsized moves in the health insurers and the drug distributors? Oh, I like these. I bet […]",
                "category": "company",
                "datetime": 1783174832,
                "headline": "Jim Cramer Says He Bets “The Gains in CVS Will Be Long-Lasting”"
              },
              {
                "id": 140799596,
                "url": "https://finnhub.io/api/news?id=9d7c8a74781110e0586d2075b0302a1ab12db07b4d4c615d7893097542bb990e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "While Wall Street fixated on a gloomy forecast, the company was making a painful but telling choice that hinted at the turnaround to come.",
                "category": "company",
                "datetime": 1783081253,
                "headline": "The Unpopular Move That Telegraphed the Elevance Health Stock Surge"
              },
              {
                "id": 140791579,
                "url": "https://finnhub.io/api/news?id=8dc403fbee8db8aad1d942b0a90f0ef7b4aed8b012426ecb0dbfe2b55e9d2556",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pacira gains a reimbursement boost as UnitedHealthcare separately covers Exparel in outpatient care, expanding access to non-opioid postsurgical pain treatment.",
                "category": "company",
                "datetime": 1782999120,
                "headline": "PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare"
              },
              {
                "id": 140792257,
                "url": "https://finnhub.io/api/news?id=c695286d7754a1888990f708cd63bc406a376127bc2185825e118715ea2c95c2",
                "image": "https://image.cnbcfm.com/api/v1/image/108329650-4ED3-MM-A-BLOCK-070126.jpg?v=1782947054&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "CNBC's Jim Cramer discusses the day's market action, the stocks he's watching and more.",
                "category": "company",
                "datetime": 1782933515,
                "headline": "Meta's new cloud business will be instantly profitable, says Jim Cramer"
              },
              {
                "id": 140772839,
                "url": "https://finnhub.io/api/news?id=6a277ca3b6991ab8e80b88b14bee749319d8ff8f2a6c7597e280f0b5c316b8da",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UnitedHealth Group (UNH) is likely to report second-quarter earnings above Wall Street's consensus,",
                "category": "company",
                "datetime": 1782828758,
                "headline": "UnitedHealth to Top Second-Quarter Earnings Views on Favorable Utilization Trends, Morgan Stanley Says"
              },
              {
                "id": 140772135,
                "url": "https://finnhub.io/api/news?id=7c0b16820ebd282600b26a580e95b5d32062b8fb552556b1e38962e35c874e2a",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 30, 2026--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 45 years, today announced its first slate of 2026 grants, dedicating over $12.2 million to programs and research focused on emotional well-being. The funding will support 13 nonprofit organizations and five university research teams focused on combating loneliness, depression and social isolation among seniors and veterans nationwide.",
                "category": "company",
                "datetime": 1782820800,
                "headline": "The Humana Foundation Deepens Investment in Emotional Health, Announcing Over $12 Million in New Grants"
              },
              {
                "id": 140771643,
                "url": "https://finnhub.io/api/news?id=933974103b907b1d72be4a7f5132c37cde71a5380376053b69d31f5124d9c4b7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "DarioHealth Corp. (NASDAQ: DRIO) (the \"Company\", \"DarioHealth\" or \"Dario\"), a leader in AI-enabled digital health solutions, today announced the appointment of Sean O'Reilly to its Advisory Board. The appointment reflects Dario's continued focus on strengthening its strategic guidance as the Company advances its channel partner-led growth strategy and moves closer to care across the payer, provider and employer markets.",
                "category": "company",
                "datetime": 1782819000,
                "headline": "Dario Appoints Former Humana Chief Compliance Officer Sean O'Reilly to Advisory Board to Support Strategic Growth and Healthcare Partnerships"
              },
              {
                "id": 140774740,
                "url": "https://finnhub.io/api/news?id=bac1556681a38492c41d8ad99cae5880494ce345262ebc615ded85f7f7858fe6",
                "image": "https://cdn.benzinga.com/files/images/story/2026/06/30/Two-Injectors-Dosing-Pens-For-Subcutaneo.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "Medicare GLP-1 coverage starts Wednesday. Here’s what patients should know about cost, eligibility and access.",
                "category": "company",
                "datetime": 1782808093,
                "headline": "Getting Wegovy Or Zepbound Through Medicare? Here's What Patients Need To Know Before Coverage Rolls Out Wednesday"
              },
              {
                "id": 140781618,
                "url": "https://finnhub.io/api/news?id=c2b9cf7db5e8e7b511f80cba972d4339f22d420c6b2bd7054751c0b254645eec",
                "image": "https://image.cnbcfm.com/api/v1/image/108139249-17461007952025-05-01t110135z_141929000_rc26x7av6mkm_rtrmadp_0_health-obesity-who.jpeg?v=1746100832&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were previously out of reach for seniors.",
                "category": "company",
                "datetime": 1782795601,
                "headline": "Medicare will start covering obesity drugs for the first time. Here's what patients should know"
              },
              {
                "id": 140781757,
                "url": "https://finnhub.io/api/news?id=5baed29654721b5d98fe3ce501ae03081ebb89e584dc62b245c3de70b534c11e",
                "image": "https://image.cnbcfm.com/api/v1/image/108262197-1770323920909-gettyimages-2260105869-bb1_2632_uxvikxrq.jpeg?v=1782775477&w=1920&h=1080",
                "source": "CNBC",
                "related": "HUM",
                "summary": "The Dow rose more than 300 points on Monday to post its first close above 52,000. Alphabet, a new addition to the 30-stock index, jumped almost 5%.",
                "category": "company",
                "datetime": 1782760725,
                "headline": "Tuesday's big stock stories: What’s likely to move the market in the next trading session"
              },
              {
                "id": 140762586,
                "url": "https://finnhub.io/api/news?id=5f2b4b890c02b3b19fefd016ce954d30cd50e96a8b966ca74f28806373f43558",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.",
                "category": "company",
                "datetime": 1782744240,
                "headline": "How CenterWell Is Driving Humana's Growth Beyond Insurance"
              },
              {
                "id": 140761652,
                "url": "https://finnhub.io/api/news?id=ec9490d78d2bbdede75602bb26eb289d1c5b1536c79f6283f5756d1080b4670b",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 12.4% gain over the past six months, beating the S&P 500 by 5.6 percentage points.",
                "category": "company",
                "datetime": 1782737415,
                "headline": "2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges"
              },
              {
                "id": 140738020,
                "url": "https://finnhub.io/api/news?id=21eee8397f16e7d74095ad3cf7e8fc458841490e5fdbb2389cbf7c1ad40e1088",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Carelon is becoming a major growth driver for ELV, boosting revenues, care efficiency and long-term earnings potential despite near-term investment pressure.",
                "category": "company",
                "datetime": 1782488700,
                "headline": "Can Carelon Drive Elevance Health's Future Earnings Growth?"
              },
              {
                "id": 140739246,
                "url": "https://finnhub.io/api/news?id=47ec2a2209086a44ad157e6195ed8a0ffc0e3023569ffaf896991b26b1a9e44d",
                "image": "https://cdn.benzinga.com/files/images/story/2025/11/06/aggregated_options_3.jpg?width=2048&height=1536",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "This whale alert can help traders discover the next big trading opportunities.\nWhales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.\nTraders often",
                "category": "company",
                "datetime": 1782480916,
                "headline": "4 Health Care Stocks With Whale Alerts In Today’s Session"
              },
              {
                "id": 140727523,
                "url": "https://finnhub.io/api/news?id=bee44d6e5e80ea447ad95d16b14bdf466a6dd9bf5bb059b006cf14e4dd1bc5f7",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "As the Q1 earnings season wraps, let’s dig into this quarter’s best and worst performers in the health insurance providers industry, including Humana (NYSE:HUM) and its peers.",
                "category": "company",
                "datetime": 1782406670,
                "headline": "Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)"
              },
              {
                "id": 140722892,
                "url": "https://finnhub.io/api/news?id=12b0414fd5accf3aa8ddbb092a2cc160affcb446696073985e2d3470b52b978e",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "In June 2026, the Illinois Department of Healthcare and Family Services selected Humana Inc. to serve members statewide in HealthChoice Illinois, the state’s Medicaid managed care program covering 102 counties, with Humana’s HealthChoice plan expected to begin operations in January 2027. At the same time, investors are weighing this new Medicaid opportunity against concerns raised by a preliminary 2027 Medicare Advantage rate update and Humana’s own ambitious membership growth expectations...",
                "category": "company",
                "datetime": 1782367644,
                "headline": "Illinois HealthChoice Medicaid Win Could Be A Game Changer For Humana’s (HUM) Margin Story"
              },
              {
                "id": 140721384,
                "url": "https://finnhub.io/api/news?id=509ea44470fd9b220f5ef5120f56ce309109d173a5fb9026a6098288f98cda4d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Humana has been selected to join Illinois' statewide Medicaid managed care program, HealthChoice Illinois. Following this selection, the company plans to launch its HealthChoice Illinois offering in January 2027, expanding its Medicaid presence in the state. Humana (NYSE:HUM) is adding a new chapter to its government program footprint with its entry into HealthChoice Illinois, a statewide Medicaid managed care program. The stock recently closed at $361.64, with returns of 17.4% over the...",
                "category": "company",
                "datetime": 1782353311,
                "headline": "Humana (HUM) Joins Illinois Medicaid Program With HealthChoice Launch Set For 2027"
              },
              {
                "id": 140715750,
                "url": "https://finnhub.io/api/news?id=392deaad22fa5d18fbbb3de9a0bc3c25155defe608767ed47db42f65e079bfee",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.",
                "category": "company",
                "datetime": 1782314700,
                "headline": "Can Humana's Margin Recovery Drive Long-Term Earnings Growth?"
              },
              {
                "id": 140717417,
                "url": "https://finnhub.io/api/news?id=f93a7b0ca1dfb02867de7f467ea74e8f67e8135f808359459d41c664d4a49722",
                "image": "",
                "source": "Benzinga",
                "related": "HUM",
                "summary": "B of A Securities  analyst Kevin Fischbeck   maintains Humana (NYSE:HUM) with a Neutral and raises the price target from $340 to $380.",
                "category": "company",
                "datetime": 1782306501,
                "headline": "B of A Securities Maintains Neutral on Humana, Raises Price Target to $380"
              },
              {
                "id": 140701640,
                "url": "https://finnhub.io/api/news?id=e87ec26e7443e12896d45adaa9be25cb0124f100504a4bce324831904b20c779",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Pzena Investment Management recently released its first-quarter 2026 commentary for “Pzena Focused Value Strategy.” A copy of the letter can be downloaded here. The equity market faced challenges in the first quarter due to the Iran conflict and the related energy price hike, compounded by continued AI-related uncertainty. Despite this volatility, energy stocks led the […]",
                "category": "company",
                "datetime": 1782220201,
                "headline": "Here’s What Hit Humana (HUM) in Q1"
              },
              {
                "id": 140700233,
                "url": "https://finnhub.io/api/news?id=c38b12817fb689102db462d2ccc0c2143ee8414e2dbef5846012f7b7e08a8efc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "CVS Health Corporation (NYSE:CVS) is one of the 10 Cheap Jim Cramer Stocks to Invest In Right Now. The New York Times, in an article published on June 11, 2026, pointed to two federal reports from the Department of Health and Human Services and stated that CVS Health Corporation (NYSE:CVS) and other major Medicare Advantage […]",
                "category": "company",
                "datetime": 1782203748,
                "headline": "CVS Health (CVS) Under the Microscope After Recent Healthcare Report"
              },
              {
                "id": 140696392,
                "url": "https://finnhub.io/api/news?id=89966c567aa0ab9e59469cab4e15beaf49cb48582424b9116a541e6eceb483af",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 22, 2026--Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.",
                "category": "company",
                "datetime": 1782160200,
                "headline": "Humana Inc. to Release Second Quarter 2026 Results on July 29, 2026"
              },
              {
                "id": 140695049,
                "url": "https://finnhub.io/api/news?id=2e2c3f7497742be1643d4d2e86e0e0da6e322ecfb2e9f5e7b47237a31fca7eea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "UNH's diversified platform, AI investments and stronger earnings outlook give it an edge over Medicare-focused rival HUM.",
                "category": "company",
                "datetime": 1782147060,
                "headline": "UnitedHealth vs. Humana: Which Healthcare Leader Is a Better Bet Now?"
              },
              {
                "id": 140670778,
                "url": "https://finnhub.io/api/news?id=bd1ba6eea0be8b23e57da68e8f92f21d120cf2fa9b34ed6a99ffd07d72b5c036",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.",
                "category": "company",
                "datetime": 1781882218,
                "headline": "1 S&P 500 Stock on Our Buy List and 2 We Ignore"
              },
              {
                "id": 140670004,
                "url": "https://finnhub.io/api/news?id=33a5887422971ea693f377a69701553c8ff339624ea7d20c1726ffa301283a0d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Former CEOs of Humana and CVS Health have been appointed as advisors to Optura, an AI focused healthcare startup. UnitedHealth Group (NYSE:UNH) is participating on the advisory side, aligning with efforts to measure and optimize return on AI investment in healthcare. The collaboration brings together major US health insurers and service providers around a shared AI platform approach. For UnitedHealth Group, a large diversified health insurer and services company, this move puts more focus...",
                "category": "company",
                "datetime": 1781871116,
                "headline": "UnitedHealth (UNH) Joins Optura As Former Humana And CVS Chiefs Sign On"
              },
              {
                "id": 140663313,
                "url": "https://finnhub.io/api/news?id=dfefa937c73e1028e63f187f3dc3fd241e34d9a0f4ea7c8917b5c00c2affc29f",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly.",
                "category": "company",
                "datetime": 1781798248,
                "headline": "2 High-Flying Stocks to Target This Week and 1 Facing Challenges"
              },
              {
                "id": 140669985,
                "url": "https://finnhub.io/api/news?id=3befb971a581643ef5598128a12003139593bfcadd0c717c21c370431db4c2ea",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.",
                "category": "company",
                "datetime": 1781789400,
                "headline": "3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound"
              },
              {
                "id": 140662486,
                "url": "https://finnhub.io/api/news?id=e95c2dd2427c646b59ca687256cb6365d1581d8409a47d6c6504ec991f1c20cc",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Optura, the enterprise healthcare platform that delivers ROAI™ (Return on AI Investment), today announced that Bruce Broussard, former President and CEO of Humana, and Karen Lynch, former President and CEO of CVS Health, have joined the company as strategic advisors, alongside a broader group of advisors from Humana, Optum, UnitedHealth Group, Horizon Blue Cross Blue Shield, BlueCross BlueShield of Tennessee, and Boston Consulting Group.",
                "category": "company",
                "datetime": 1781787600,
                "headline": "Bruce Broussard and Karen Lynch Lead a Group of Healthcare and Music Industry Luminaries Joining Optura as Strategic Advisors"
              },
              {
                "id": 140652753,
                "url": "https://finnhub.io/api/news?id=f816292c4cc1a836354f9db6258b904847bb65dcad6c9dd3e2a121251f9b0be8",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 17, 2026--Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State",
                "category": "company",
                "datetime": 1781697600,
                "headline": "Humana Awarded Statewide Illinois HealthChoice Medicaid Contract, Expanding Access to Care Across the State"
              },
              {
                "id": 140645758,
                "url": "https://finnhub.io/api/news?id=920d7e0373fa1f369733ebdb85721d3ee12e827e4bb631d1c07561d28b3c699d",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "Long before the stock surged, the company had been openly broadcasting its decision to choose profit over scale. The market initially ignored the signal - until the turnaround became undeniable.",
                "category": "company",
                "datetime": 1781624687,
                "headline": "Why Did UnitedHealth Stock Choose Pain Over Growth?"
              },
              {
                "id": 140644635,
                "url": "https://finnhub.io/api/news?id=a0cb1ba10580396788827af3aae39c4050267d5c2d9d9d8e7b5e974e1ea28020",
                "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
                "source": "Yahoo",
                "related": "HUM",
                "summary": "LOUISVILLE, Ky., June 16, 2026--Humana, CenterWell and National Hispanic Medical Association announce 2026 Resident Physician Scholarship Program recipients.",
                "category": "company",
                "datetime": 1781607600,
                "headline": "Humana, CenterWell and National Hispanic Medical Association Announce 2026 Resident Physician Scholarship Program Recipients"
              }
            ],
            "data_source": "finnhub_news_keyword_model",
            "article_count": 8,
            "negative_hits": 0,
            "positive_hits": 3,
            "recomputed_at_score": true,
            "sentiment_score_raw": 0.9,
            "source_article_count": 74,
            "discarded_article_count": 66
          },
          "sentimentPoints": 4
        }
      },
      "技術信號": {
        "max": 30,
        "raw": 16.7,
        "grade": "較差",
        "items": {
          "bbPoints": 2.4,
          "adxPoints": 3,
          "sarPoints": 1.2000000000000002,
          "vcpPoints": 1.6,
          "macdPoints": 2.4,
          "vcpPayload": {
            "vcp_pass": false,
            "vcp_score": 1.6,
            "vcp_reason": "波幅收縮(25.1%→7%)；站上MA50；Ready=N；Confirm=N",
            "vcp_metrics": {
              "up_days": 6,
              "vol_ref": 1448960,
              "down_days": 3,
              "vcp_ready": false,
              "above_ma50": true,
              "avg_vol_10": 1315420,
              "avg_vol_20": 1520780,
              "avg_vol_30": 1448960,
              "range_pct_10": 0.06960253908086994,
              "range_pct_20": 0.16026702648864036,
              "range_pct_30": 0.25064685751793475,
              "up_expand_ok": false,
              "lookback_used": 59,
              "near_20d_high": true,
              "contraction_ok": true,
              "down_shrink_ok": false,
              "up_expand_days": 1,
              "breakout_20d_ok": false,
              "vol_ratio_10_30": 0.9078373454063604,
              "dist_to_20d_high": 0.06872286746987953,
              "down_shrink_days": 2,
              "breakout_level_20d": 415,
              "vcp_breakout_confirm": false,
              "contraction_ratio_10_30": 0.2776916486012182
            },
            "vcp_name_en": "Volatility Contraction Pattern",
            "vcp_name_zh": "波動收縮形態",
            "vol_contraction": true
          },
          "kdjAdxPoints": 0.5,
          "rsiKdjPoints": 2.4,
          "volumeWeight": 2,
          "maCrossPoints": 1.6,
          "shortRsiPoints": 0,
          "shortMacdPoints": 0.4,
          "volConfirmPoints": 0,
          "volumePointsTechnical": 1.2
        }
      },
      "風險管理": {
        "max": 10,
        "grade": "較差",
        "items": {
          "position": {
            "score": 1.3,
            "details": {
              "atrPct": 4.149192606365332,
              "turnoverUsdM": 864.87153653817,
              "liquidityPoints": 0.6,
              "volatilityPoints": 0.7
            }
          },
          "rrPoints": 1.4,
          "stopLevels": {
            "symbol": "US.HUM",
            "rr_range": "1:1.0-1:2.5",
            "risk_profile": "中等",
            "stop_loss_price": 354.4084,
            "strength_details": {
              "ma_score": 1.5,
              "atr_score": 1,
              "rsi_score": 2,
              "macd_score": 1.5,
              "volume_score": 2
            },
            "market_adjustment": 1,
            "risk_reward_ratio": 1,
            "stop_loss_percent": 8.3,
            "take_profit_price": 419.487,
            "target_multiplier": 1.9,
            "technical_strength": 1.63,
            "take_profit_percent": 8.5
          },
          "positionPoints": 1.3,
          "stopLossPoints": 1.2,
          "diversification": {
            "score": 2,
            "details": {
              "method": "sector concentration proxy; no portfolio holdings used",
              "sector": "Health Care",
              "concentratedSectorPenalty": 0
            }
          },
          "riskRewardRatio": 1.2,
          "stopLossPercent": 8.298385212730665,
          "diversificationPoints": 2
        }
      }
    }
  },
  "modelVersion": "cursor_18_27_news_v2_160",
  "providerErrors": [],
  "rankingScoreMax": 160,
  "dataCompleteness": {
    "complete": true,
    "missingFields": [],
    "optionalInputs": [
      "institutionalData"
    ],
    "requiredInputs": [
      "fundamentals",
      "marketContext.VIX",
      "marketContext.SPY",
      "marketContext.QQQ",
      "catalystData",
      "sentimentData",
      "ATR",
      "sector"
    ],
    "optionalInputWarnings": []
  },
  "technicalIndicators": {
    "adx": 92.86,
    "atr": {
      "atr": 16.0358,
      "rule": "ATR / current price; lower volatility scores higher",
      "score": 4,
      "atr_pct": 4.15
    },
    "cci": {
      "rule": "Cursor_18.24 CCI bands",
      "level": "適中偏強",
      "score": 8,
      "value": 57.98
    },
    "cmf": {
      "rule": "Cursor_18.24 CMF bands",
      "level": "派發",
      "score": 2,
      "value": -0.0826
    },
    "kdj": {
      "d": 58.91,
      "j": 19.32,
      "k": 45.71,
      "rule": "Cursor_18.24 K/D cross",
      "score": 0,
      "signal": "死叉"
    },
    "mfi": {
      "rule": "Cursor_18.24 MFI bands",
      "level": "平衡",
      "score": 6,
      "value": 51.69
    },
    "obv": {
      "rule": "Cursor_18.24 recent_slope vs previous_slope",
      "score": 6,
      "trend": "有流入",
      "value": 34036383,
      "recentSlope": 155278.3,
      "previousSlope": 415530
    },
    "rsi": 55.39,
    "sar": {
      "rule": "Cursor_18.24 Parabolic SAR",
      "score": 4,
      "trend": "下降",
      "value": 415,
      "position": "SAR喺價上",
      "distancePct": 7.38,
      "previousTrend": "上升"
    },
    "ma50": 344.7634,
    "macd": {
      "macd": 16.2059787580057,
      "trend": "中性偏多",
      "signal": 19.01978013162062,
      "histogram": -2.813801373614922
    },
    "vwap": {
      "rule": "Cursor_18.24 VWAP 20D consecutive close",
      "score": 10,
      "value": 384.8844,
      "position": "連續5日>VWAP",
      "consecutiveAbove": 41
    },
    "volume": {
      "rule": "Cursor_18.24 volume ratio",
      "level": "有量",
      "ratio": 1.45,
      "score": 6,
      "avgVolume": 1547816,
      "currentVolume": 2237817
    },
    "derived": {
      "ma20": 386.8525,
      "ma50": 344.7634,
      "prevClose": 407.78,
      "avgVolume10": 1370272,
      "avgVolume20": 1547816,
      "changePercent": -5.22,
      "avgVolumeForScore": 1547816
    },
    "ma_cross": {
      "ma20": 386.8525,
      "ma50": 344.7634,
      "rule": "Cursor_18.24 MA20/MA50 cross",
      "cross": "多頭",
      "score": 4,
      "prevMa20": 386.003,
      "prevMa50": 341.793,
      "spreadPct": 12.21,
      "isVolumeBreakout": true
    },
    "bollinger": {
      "lower": 352.8766,
      "upper": 420.8284,
      "position": "中間"
    },
    "rsi_short": 38.82,
    "macd_short": {
      "macd": 0,
      "trend": "中性",
      "signal": 0,
      "histogram": 0
    },
    "volume_ratio": {
      "ratio": 1.45
    }
  }
}

Raw metrics JSON

 
{
  "close": 386.48,
  "volume": 2237817,
  "changePercent": -5.22
}

Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.